KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Interest Expenses (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Interest Expenses for 17 consecutive years, with $12.1 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 0.82% to $12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.0 million through Dec 2025, changed 0.2% year-over-year, with the annual reading at $49.0 million for FY2025, 0.2% changed from the prior year.
  • Interest Expenses for Q4 2025 was $12.1 million at Bio-Rad Laboratories, down from $12.3 million in the prior quarter.
  • The five-year high for Interest Expenses was $12.6 million in Q2 2025, with the low at $363000.0 in Q2 2021.
  • Average Interest Expenses over 5 years is $9.3 million, with a median of $12.1 million recorded in 2024.
  • The sharpest move saw Interest Expenses tumbled 93.68% in 2021, then skyrocketed 3105.77% in 2022.
  • Over 5 years, Interest Expenses stood at $364000.0 in 2021, then surged by 3105.77% to $11.7 million in 2022, then rose by 5.6% to $12.3 million in 2023, then dropped by 0.99% to $12.2 million in 2024, then decreased by 0.82% to $12.1 million in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $12.1 million, $12.3 million, and $12.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.